Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Desmogalen

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of April 22, 2026
    Enforcement Report - Week of April 22, 2026

    22 Apr 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-22-2026-72558.pdf

    FDA
    22 Apr 2026
    Share Share
    Caplin Steriles Gets FDA Approval For Desmopressin
    Caplin Steriles Gets FDA Approval For Desmopressin

    02 Mar 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/caplin-steriles-gets-fda-approval-for-desmopressin-19251

    INDPHARMAPOST
    02 Mar 2026
    Share Share
    Eton Pharma’s Desmoda Receives Approval in US
    Eton Pharma’s Desmoda Receives Approval in US

    25 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219873

    FDA
    25 Feb 2026
    Share Share
    Eton Pharma's New Drug ET-600 Receives FDA Acceptance
    Eton Pharma's New Drug ET-600 Receives FDA Acceptance

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3111576/0/en/Eton-Pharmaceuticals-Announces-FDA-Acceptance-of-New-Drug-Application-for-ET-600-Desmopressin-Oral-Solution.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share
    Eton Pharmaceuticals Submits NDA for Desmopressin Oral Solution
    Eton Pharmaceuticals Submits NDA for Desmopressin Oral Solution

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069026/0/en/Eton-Pharmaceuticals-Announces-Submission-of-NDA-for-ET-600-Desmopressin-Oral-Solution.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Eton Pharmaceuticals Reports Positive Study Results for ET-600
    Eton Pharmaceuticals Reports Positive Study Results for ET-600

    14 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/14/3042855/0/en/Eton-Pharmaceuticals-Announces-Positive-Pivotal-Clinical-Study-Results-for-Product-Candidate-ET-600.html

    GLOBENEWSWIRE
    14 Mar 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.